🔎 Trials Near Me

Dachaigh › Cancer Ovarian › North Carolina › Durham

Sgrùdaidhean clionaigeach Cancer Ovarian ann an Durham, NC

Tha 27 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

The Vanguard Study: Testing a New Way to Screen for Cancer

A’ fastadhFàilte do shaor-thoilich fhallain
  • Durham VA Medical Center, Durham
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Aoisean 45 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06995898

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

A’ fastadhÌre 2/3
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
  • University of North Carolina-Hillsborough Campus, Hillsborough · 13 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

A’ fastadhÌre 2
  • Duke University Medical Center, Durham
Gach aois · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564377

A Study of PHST001 in Advanced Solid Tumors

A’ fastadhÌre 1
  • Duke Cancer Institute, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

A’ fastadhÌre 1/2
  • Duke University, Durham
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

A’ fastadhÌre 2
  • University of North Carolina Medical Center /ID# 275307, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT06890338

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

A’ fastadhÌre 2
  • Site 0259 - Duke Cancer Center, Durham
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT05128825

DESTINY-PANTUMOUR04

A’ fastadhSgrùdadh amharc
  • Research Site, Durham
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07124000

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

A’ fastadhÌre 3
  • Duke Cancer Institute, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

A’ fastadhÌre 1
  • Duke University Medical Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07213791

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

A’ fastadhÌre 3
  • Duke Cancer Center ( Site 0012), Durham
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Sult 2026 · NCT07318558

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

A’ fastadhSgrùdadh amharc
  • UNC- Chapel Hill, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT05059444

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

A’ fastadhÌre 3
  • Duke, Durham
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 14 Sult 2026 · NCT04575935

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

A’ fastadh
  • Duke University Medical Center, Durham
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Aoisean 35 gu 50 · Banairean · Air ùrachadh 7 Lùna 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

A’ fastadhÌre 3
  • Duke University Medical Center, Durham
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06580314

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

A’ fastadhÌre 1/2
  • Duke University, Durham
Aoisean 18 gu 75 · Banairean · Air ùrachadh 13 Iuch 2026 · NCT07322094

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

A’ fastadhÌre 3
  • UNC Hospital, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Iuch 2026 · NCT06819007

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

A’ fastadhÌre 1
  • Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 19 Cèit 2026 · NCT06305299

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

A’ fastadhÌre 3
  • Duke Cancer Center, Durham
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 16 Gibl 2026 · NCT05659381

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

A’ fastadh
  • Duke Cancer Center, Durham
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 13 Gibl 2026 · NCT06710548

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

A’ fastadhÌre 1
  • Site 0259, Durham
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 7 Gibl 2026 · NCT04516447

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

A’ fastadh
  • Duke University Hospital, Durham
Aoisean 25 gu 50 · Banairean · Air ùrachadh 6 Gibl 2026 · NCT04294927

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

A’ fastadhÌre 1/2
  • Duke Cancer Center/ DUMC, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT05735080

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

A’ fastadhÌre 1
  • Duke Cancer Institute, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gearr 2026 · NCT06778863

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

A’ fastadhÌre 2
  • Duke Cancer Center, Durham
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 23 Dùbh 2025 · NCT06690775

Multimedia Aid for Genetic Testing in Gynecologic Oncology

A’ fastadh
  • Univeristy of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 12 Samh 2025 · NCT07084168

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Chapel Hill · 10 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Sgrùdaidhean Cancer Ovarian ann am bailtean eile

Sgrùdaidhean eile ann an Durham

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.